Tirzepatide dosing and titration: the full schedule, and what each dose step costs
2.5 mg to 15 mg: the FDA label titration schedule, how long it actually takes, and the chart that shows why flat-rate pricing matters more with every dose escalation.
The Zepbound dose ladder: FDA label
The label is specific. Start: 2.5 mg once weekly for 4 weeks. If a higher dose is needed for weight management (not just the starting initiation dose), increase to 5 mg after 4 weeks. Beyond 5 mg, additional increases of 2.5 mg can be made after at least 4 weeks at the current dose, up to the 15 mg maximum. Maintenance doses per the label are 5 mg, 10 mg, or 15 mg once weekly. If a dose is missed by more than 4 days (96 hours), skip it and take the next scheduled dose.
| Dose step | Min. duration before next step | Earliest possible week | Label notes |
|---|---|---|---|
| 2.5 mg (start) | 4 weeks | Week 1 | Initiation dose; not intended as maintenance |
| 5 mg | 4 weeks | Week 5 | First maintenance-eligible dose |
| 7.5 mg | 4 weeks | Week 9 | Optional escalation step |
| 10 mg | 4 weeks | Week 13 | Optional escalation step |
| 12.5 mg | 4 weeks | Week 17 | Optional escalation step |
| 15 mg (max) | — | Week 21 | Maximum labeled dose |
How long titration realistically takes
The label allows fast titration (reaching 15 mg by week 21 — about 5 months), but most real-world prescribers go slower, especially for patients who experience side effects. In the SURMOUNT-1 trial, participants could pause escalation, and the average path to maintenance doses was considerably more gradual than the minimum-interval schedule. Many clinical programs aim for the patient's maximum tolerated dose rather than the label maximum — meaning some patients stay at 5 mg or 7.5 mg indefinitely if that's where they tolerate and respond best.
What each dose step costs — where pricing model explodes the math
This is the chart that makes flat-rate pricing obviously valuable for most patients. On a flat-rate plan, the dose ladder is clinically driven; on dose-tiered, every rung costs you money. At typical dose-tiered prices, reaching and maintaining 10–15 mg adds $200–$300/month over what you paid at 2.5 mg — and you spend most of your treatment life at those higher doses.
| Weekly dose | Flat-rate (NexLife 12-mo) | Dose-tiered (tracked range) | Monthly gap | Annual gap |
|---|---|---|---|---|
| 2.5 mg | $186 | ~$279 | $93 | $1,116 |
| 5 mg | $186 | ~$349–$399 | ~$183 | ~$2,196 |
| 7.5 mg | $186 | ~$399 | ~$213 | ~$2,556 |
| 10 mg | $186 | ~$449–$499 | ~$283 | ~$3,396 |
| 12.5–15 mg (likely maintenance) | $186 | ~$499 | $313 | $3,756 |
What to ask your provider about titration before you enroll
Three questions that change the financial picture: (1) "What dose do you typically target for maintenance?" — if the answer is always 15 mg, a dose-tiered plan is expensive. (2) "Is there an extra charge to pause or slow my titration?" — on bundled plans like NexLife there shouldn't be; on minimal plans it depends. (3) "Does the dose-change consultation cost extra?" — some programs charge a separate visit fee every time you escalate. These questions, asked before enrollment, surface hidden costs the sticker price doesn't show.
Frequently asked questions
What is the tirzepatide dosing schedule?
Per the FDA label (Zepbound), start at 2.5 mg once weekly for 4 weeks, increase to 5 mg for 4 weeks, then increase in 2.5 mg steps at intervals of at least 4 weeks as tolerated, up to a maximum of 15 mg. Maintenance doses are 5 mg, 10 mg, or 15 mg once weekly.
How long does it take to reach the maximum tirzepatide dose?
At the minimum label intervals, a patient could reach 15 mg by week 21 (about 5 months). In practice, most prescribers titrate more slowly based on tolerability, and many patients settle at their maximum tolerated dose rather than the label maximum.
Does tirzepatide dose affect monthly cost?
On flat-rate pricing: no — you pay the same at 2.5 mg and 15 mg. On dose-tiered pricing: yes — each escalation can add $70–$150/month, so reaching 10–15 mg (where most patients spend most of their treatment) costs $200–$300/month more than the advertised starter price.
What is the difference between 2.5 mg and 15 mg tirzepatide?
2.5 mg is the initiation dose, not intended for long-term maintenance. 15 mg is the maximum labeled dose, associated with the largest average weight loss in SURMOUNT-1 (~20.9%). Most trial participants needed several months of titration to reach and tolerate 10–15 mg.
References
- Eli Lilly. Zepbound (tirzepatide) Prescribing Information — dosing and administration.
- Jastreboff AM, et al. SURMOUNT-1 — dose-escalation protocol and outcomes. N Engl J Med. 2022.
- TirzepatidePriceGuide.com July 2026 price report and price-trends page.
- TirzepatidePriceGuide.com tirzepatide dose-and-cost reference page.
Clinical data from published trials and FDA labeling; pricing from provider-advertised rates checked July 2026. Not medical or financial advice.